Shenzhen Neptunus Bioengineering Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

5,945.15

5,154.79

7,201.42

6,935.91

7,375.59

5,764.60

7,921.25

Other Operating Income

0.00

Total Operating income

5,945.15

5,154.79

7,201.42

6,935.91

7,375.59

5,764.60

7,921.25

Raw Material Cost

5,393.65

4,728.08

6,601.78

6,325.88

6,735.23

5,391.63

7,232.29

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

118.75

179.97

147.13

150.54

147.12

259.47

173.80

Selling and Distribution Expenses

343.94

723.10

395.63

396.71

474.32

901.15

457.96

Other Expenses

-10.88

-17.87

-13.80

-14.11

-13.68

-25.46

-16.42

Total Expenditure (Excl Depreciation)

5,747.52

5,452.42

7,006.57

6,732.06

7,219.85

6,297.62

7,699.87

Operating Profit (PBDIT) excl Other Income

197.60000000000002

-297.6

194.89999999999998

203.79999999999998

155.7

-533

221.4

Other Income

-11.66

-48.90

-3.17

8.17

98.22

-11.50

25.15

Operating Profit (PBDIT)

163.43

-309.86

239.68

246.18

291.91

-543.70

288.26

Interest

118.75

179.97

147.13

150.54

147.12

259.47

173.80

Exceptional Items

2.45

-125.44

0.07

0.05

0.02

-481.43

9.77

Gross Profit (PBDT)

551.50

426.71

599.64

610.02

640.36

372.97

688.96

Depreciation

0.00

57.44

54.07

70.28

Profit Before Tax

47.13

-672.71

35.18

41.61

90.75

-1,354.88

53.95

Tax

21.01

-46.40

31.81

30.05

37.80

-57.42

43.27

Provisions and contingencies

0.00

Profit After Tax

14.49

-588.76

-5.98

7.97

23.72

-1,239.63

0.81

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

14.49

-588.76

-5.98

7.97

23.72

-1,239.63

0.81

Share in Profit of Associates

0.00

Minority Interest

10.58

-32.03

9.40

3.90

29.24

-53.52

9.76

Other related items

0.00

Consolidated Net Profit

25.07

-620.80

3.42

11.87

52.96

-1,293.16

10.56

Equity Capital

0.00

Face Value

1.0

Reserves

1,241.62

1,227.11

1,822.31

1,829.80

1,818.96

1,795.23

3,035.90

Earnings per share (EPS)

0.01

-0.22

-0.0

0.0

0.01

-0.47

0.0

Diluted Earnings per share

0.01

-0.22

-0.0

0.0

0.01

-0.47

0.0

Operating Profit Margin (Excl OI)

2.95%

-6.18%

2.57%

2.65%

1.89%

-10.45%

2.43%

Gross Profit Margin

0.79%

-11.94%

1.29%

1.38%

1.96%

-22.28%

1.57%

PAT Margin

0.24%

-11.42%

-0.08%

0.11%

0.32%

-21.5%

0.01%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is 15.33% vs -28.42% in Dec 2025

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 104.04% vs -18,358.82% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 167.09% vs -207.45% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is -34.06% vs 22.37% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Shenzhen Neptunus Bioengineering Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(CNY)

Change(%)

Net Sales

5,945.15

Other Operating Income

0.00

Total Operating income

5,945.15

Raw Material Cost

5,393.65

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

118.75

Selling and Distribution Expenses

343.94

Other Expenses

-10.88

0.00

-10.88

Total Expenditure (Excl Depreciation)

5,747.52

Operating Profit (PBDIT) excl Other Income

197.62

0.00

197.62

Other Income

-11.66

Operating Profit (PBDIT)

163.43

Interest

118.75

Exceptional Items

2.45

Gross Profit (PBDT)

551.50

Depreciation

0.00

Profit Before Tax

47.13

Tax

21.01

Provisions and contingencies

0.00

Profit After Tax

14.49

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

14.49

Share in Profit of Associates

0.00

Minority Interest

10.58

Other related items

0.00

Consolidated Net Profit

25.07

Equity Capital

0.00

Face Value

1.00

0.00

Reserves

1,241.62

Earnings per share (EPS)

0.01

Diluted Earnings per share

0.01

Operating Profit Margin (Excl OI)

2.95%

0.00

2.95%

Gross Profit Margin

0.79%

0.00

0.79%

PAT Margin

0.24%

0.00

0.24%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 594.51 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 15.33% vs -28.42% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -19.40% vs -8.81% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 2.51 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 104.04% vs -18,358.82% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -52.64% vs -23.41% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 17.51 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 167.09% vs -207.45% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -9.60% vs -46.62% in Mar 2025

Quarterly - Interest

Interest 11.87 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -34.06% vs 22.37% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -19.31% vs -28.45% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 2.95%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025